4Sun Y, Yu XL, Luo W, et al. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity - modulated radiotherapy[J]. Radioth- er Oncol,2014,110(3) :390 - 397.
5Lee AW, Ng WT, Chan YH, et al. The battle against nasopharyn- geal cancer[J]. Radiother Oncol, 2012,104(3) : 272 - 278.
6Lee AW, Fee WE Jr, Ng WT, et al. Nasopharyngeal carcinoma: salvage of local recurrence[J]. Oral Oncol,2012,48(9) :768 - 774.
7Chen J, Dassarath M, Yin Z, et al. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management[J]. Radiat Oncol, 2011 (6) : 128.
8Cox JD, Tetz J, Pajak TF. Toxicity criteria of the Radiation Ther- apy Oncology Group(RTOG) and the European Organization for Research and Treatment of Cancer(EORTC)[J]. Int J Radiat On- col Biol Phys,1995,31(5) :1341 - 1346.
9Vujaskovic Z, Batinic- Haberle I, Rabbani ZN, et al. Catalytic metalloporphyrin antioxidant with superoxide dismutase(SOD) mimetic properties protects lungs from radiation - induced injury [J]. Int J Radiat Oncof,2002,54(2) :221 - 222.
